Global Markets
AstraZeneca (AZN LN) EMA's CHMP adopted a positive opinion recommending a change to the terms of the marketing authorisation for AstraZeneca's Leqvio
Related stocks
1 stocksWhat do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
